Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02581215 |
| Title | Phase II Randomized Trial of FOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Walid Shaib, MD |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic-Arizona | Scottsdale | Arizona | 85259 | United States | Details | |
| Emory University: Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| Community Healthcare System | Munster | Indiana | 46321 | United States | Details | |
| University of Louisville, James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | United States | Details | |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | United States | Details | |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | United States | Details | |
| Thomas Jefferson University Kimmel Cancer Center | Philadelphia | Pennsylvania | 19107 | United States | Details |